¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

KSMO ºÎ»ê¿ï»ê°æ³²/´ë±¸°æºÏÁöȸ °øµ¿ ½ÉÆ÷Áö¾ö : 2024-06-14

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

KSMO ºÎ»ê¿ï»ê°æ³²/´ë±¸°æºÏÁöȸ °øµ¿ ½ÉÆ÷Áö¾ö : 2024-06-14
±³À°ÀÏÀÚ : 2024-06-14
±³À°Àå¼Ò : ÆÄÅ©ÇϾæÆ® ºÎ»ê

±³À°ÁÖÁ¦ : KSMO ºÎ»ê¿ï»ê°æ³²/´ë±¸°æºÏÁöȸ °øµ¿ ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇÑÁ¾¾ç³»°úÇÐȸ(17.5 ¸íĪº¯°æ Çѱ¹ÀÓ»ó¾ÏÇÐȸ)
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÁ¾¾ç³»°úÇÐȸ ºÎ»ê ¿ï»ê °æ³²Áöȸ

´ã´çÀÚ : Â÷¹ÎÁÖ
¿¬¶ôó : 02-4044-5337

À̸ÞÀÏ : members@ksmo.or.kr

±³À°Á¾·ù : ³»°ú, ¹æ»ç¼±Á¾¾çÇаú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡

Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 3 ½Ã°£ 50ºÐ

¼¼ºÎ¼ö°­·á : 10,000¿ø  

ºñ°í "ÀÇ»ç: 10000¿ø

°£È£»ç ¹× ±âŸ : ¹«·á" 


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 14ÀÏ ÆÄÅ©ÇϾæÆ® ºÎ»ê 2F Ballroom 14:30~14:55 Gastric cancer À庴ÀÏ(¿µ³²´ëÇб³º´¿ø)

±³À°½Ã°£ 06¿ù 14ÀÏ ÆÄÅ©ÇϾæÆ® ºÎ»ê 2F Ballroom 14:55~15:20 Colorectal cancer ¿À»óº¸(¾ç»êºÎ»ê´ëÇб³º´¿ø)

ÈÞ½Ä 06¿ù 14ÀÏ ÆÄÅ©ÇϾæÆ® ºÎ»ê 2F Ballroom 15:20~15:30 Coffee Break ( )

±³À°½Ã°£ 06¿ù 14ÀÏ ÆÄÅ©ÇϾæÆ® ºÎ»ê 2F Ballroom 15:30~16:10 Quality-based Biosimilar Development: Onbevzi¢ç Á¤Çö¿±(°í½Å´ëÇб³º´¿ø)

±³À°½Ã°£ 06¿ù 14ÀÏ ÆÄÅ©ÇϾæÆ® ºÎ»ê 2F Ballroom 16:10~16:40 Revolutionizing Standard of Care in mBC Treatment: From HER2-Positive to HER2loww °í¼öÁø(¿ï»ê´ëÇб³º´¿ø)

±³À°½Ã°£ 06¿ù 14ÀÏ ÆÄÅ©ÇϾæÆ® ºÎ»ê 2F Ballroom 16:40~17:10 Push the paradigm of third-line HER2 positive gastric cancer treatment : Focus on Efficacy and Adverse event management of Enhertu °­º´¿í(Ä¥°î°æºÏ´ëÇб³º´¿ø)

±³À°½Ã°£ 06¿ù 14ÀÏ ÆÄÅ©ÇϾæÆ® ºÎ»ê 2F Ballroom 17:10~17:30 3yr long-term Evidence of IO Based 1st Line aGC Treatment for PD-L1 All-comer Population ÀÓÇö¼ö(¿ï»ê´ëÇб³º´¿ø)

±³À°½Ã°£ 06¿ù 14ÀÏ ÆÄÅ©ÇϾæÆ® ºÎ»ê 2F Ballroom 17:30~17:50 IO/IO Regimen, a Life-saving and Changing Treatment in aRCC Á¤ÁöÀ±(¿µ³²´ëÇб³º´¿ø)

ÈÞ½Ä 06¿ù 14ÀÏ ÆÄÅ©ÇϾæÆ® ºÎ»ê 2F Ballroom 17:50~18:00 Coffee Break ( )

±³À°½Ã°£ 06¿ù 14ÀÏ ÆÄÅ©ÇϾæÆ® ºÎ»ê 2F Ballroom 18:00~18:20 Software Tips for Medical Paper Writing °í¼¼ÀÏ(â¿ø°æ»ó±¹¸³´ëÇб³º´¿ø)

±³À°½Ã°£ 06¿ù 14ÀÏ ÆÄÅ©ÇϾæÆ® ºÎ»ê 2F Ballroom 18:20~18:40 AI in Medical Paper Writing ÀÌÀÎÈñ(Ä¥°î°æºÏ´ëÇб³º´¿ø)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" KSMO ºÎ»ê¿ï»ê°æ³²/´ë±¸°æºÏÁöȸ °øµ¿ ½ÉÆ÷Áö¾ö : 2024-06-14""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ)2024³âµµ Ãæû³²µµÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-15
´ÙÀ½±Û 2024³â ´ëÇѺҾÈÀÇÇÐȸ Ãá°èÇмú´ëȸ (´Ù½Ã, °Ü¿ï³ª¹«¿¡¼­ º½ ³ª¹«¿¡·Î From Traditional approaches to Innovation in Psychiatry) : 2024-06-14
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21009 ºÎ»ê ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ºÎ»ê°æ³²Áöȸ Çмúȸ : 2024-06-25 0 4 2024-06-17
21008 °æ³² â¿ø½Ã ¼Ò¾Æû¼Ò³â°úÁöȸ ¿¬¼ö°­ÁÂ(¼Ò¾Æ ¼ÒÈ­±â Áúȯ) : 2024-06-25 0 5 2024-06-17
21007 Ãæ³² ´Ü±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú °³¿øÀÇ Çмúȸ(±¸°­°ÇÁ¶Áõ) : 2024-06-25 0 4 2024-06-17
21006 ¼­¿ï (¿Â¶óÀÎ) 2024³â 6¿ù ¼Ò¾Æ½ÉÃÊÀ½ÆÄ Áý´ãȸ : 2024-06-24 0 3 2024-06-17
21005 °æ±â 2024³â ¼Ò¾Æ¼ö¸é¿¬±¸È¸ Á¦2Â÷ Áý´ãȸ(¿Â¶óÀÎ) : 2024-06-24 0 2 2024-06-17
21004 Ãæ³² ´Ü±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú (¿Â¶óÀÎ) 29th Vestibular Function Test Workshop : 2024-06-23 0 3 2024-06-17
21003 ¼­¿ï ´ëÇѳëÀο©¼ºÀÇÇÐȸ Á¦33Â÷ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö°­Á : 2024-06-23 0 1 2024-06-17
21002 ¼­¿ï ´ëÇÑÁ¤ÇüÅëÁõÀÇÇÐȸ - Á¦5ȸ ½ÉÈ­ ½ÉÆ÷Áö¾ö : 2024-06-23 0 2 2024-06-17
21001 ºÎ»ê ´ëÇÑÁ·ºÎÁ·°üÀýÇÐȸ - Á¦19Â÷ Çмú´ëȸ : 2024-06-23 0 2 2024-06-17
21000 ¼­¿ï 2024³â 6¿ù ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ ¿¬¼ö°­Á : 2024-06-23 0 3 2024-06-17
20999 ¼­¿ï Á¦ 10ȸ ´ëÇÑ»êºÎÀΰúÃÊÀ½ÆÄÇÐȸ ¼­¿ïÁöȸ ¿¬¼ö°­Á : 2024-06-23 0 1 2024-06-17
20998 ¼­¿ï ´ëÇѵÎÅëÇÐȸ 2024³â Ãá°èÇмú´ëȸ : 2024-06-23 0 1 2024-06-17
20997 ´ë±¸ 2024³â ´ëÇѼÒÈ­±âÇÐȸ ´ë±¸°æºÏÁöȸ ¿¬¼ö°­Á : 2024-06-23 0 2 2024-06-17
20996 °æ±â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ °æÀÎÁöȸ Á¦7ȸ °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-23 0 10 2024-06-16
20995 ¼­¿ï Á¦18ȸ ´ëÇѺñ°úÇÐȸ ½ÉÆ÷Áö¾ö : 2024-06-23 0 8 2024-06-16
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷